ARCHIVES

Clinical Oncology Grant Funding: The History Of a Controversy

This article is from The Cancer Letter archive.

Vol. 19 No. 30 | July 23, 1993

Download PDF Visit The Full Archive

Related Articles

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

January 16, 2009

ODAC Recommends FDA Approval For Grain Tumor Implant

June 21, 1996

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987

ONS Adopts Position Statement On Rehabilitation

May 5, 1989

Cullen To Leave NCI, Will Become Director Of AMC Cancer Center; Nixon May Join ACS

April 14, 1989

Science Policcy: HHS Concludes NIH May und Human Stem Cell REsearch

January 22, 1999